Cellyrix is pioneering a new paradigm in cancer treatment by leveraging single-cell RNA sequencing and AI to unravel the complexities of tumor heterogeneity. This will be used to develop innovative therapies that target root causes of disease progression, resistance, and relapse, ultimately improving patient outcome.